Mitochondrial Membrane Protein-Associated Neurodegeneration is a rare
monogenic form of neurodegeneration characterized by iron accumulation
in the brain. It is due to variants in the orphan gene C19orf12.
Since its definition in 2011, many scientific groups have investigated
the clinical features and molecular underpinnings of the disorder. In
this review, we summarize the main points of progress in this field,
trying to highlight the issues that need further attention and efforts
to speed up the diagnostic path, improve the existing treatment options,
and define targeted therapies.